,The healthcare-associated infection component of CDC’s EIP engages a network of state health departments and their academic medical center partners to help answer critical questions about emerging HAI threats, advanced infection tracking methods, and antibiotic resistance in the United States. Information gathered through this activity will play a key role in shaping future policies and recommendations targeting HAI prevention.,

NNDSS - TABLE 1KK. Vancomycin-resistant Staphylococcus aureus to Varicella morbidity - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. Note: This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. Footnotes: U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases — The reporting jurisdiction did not submit any cases to CDC. N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable — This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized. Cum: Cumulative year-to-date counts. Max: Maximum — Maximum case count during the previous 52 weeks. * Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).

This dataset includes central line-associated bloodstream infection (CLABSI) data reported by California hospitals to the California Department of Public Health (CDPH), Healthcare-Associated Infections (HAI) Program, via the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN). Hospital types include acute care, critical access, long-term acute care, free-standing rehabilitation hospitals, as well as acute rehabilitation units that report data separately. CLABSI data for each hospital include the number of infections observed (reported) and predicted (based on national baseline data), the number of central line-days, the Standardized Infection Ratio (SIR) and associated 95% confidence intervals, and statistical interpretation to show whether CLABSI incidence was the same (no different), better (lower), or worse (higher) than the national baseline. Central line insertion practices (CLIP) adherence percent for each hospital is calculated from data reported by all critical care locations (i.e., critical care areas, neonatal critical care, and one special care area, "Oncology - Medical/Surgical Critical Care"). In 2021, the CLIP reporting requirement to CDPH via NHSN was discontinued. CLABSI SIRs are influenced by clinical and infection control practices related to central line insertion and infection control maintenance practices, patient-based risk factors, and surveillance and reporting methods. Health and Safety Code section 1288.55(a)(2) requires general acute care hospitals to report to CDPH all cases of CLABSI identified in their facilities. For general information about NHSN, surveillance definitions, and reporting requirements for CLABSI, please visit: https://www.cdc.gov/nhsn/index.html To link the CDPH facility IDs with those from other Departments, including OSHPD, please reference the "Licensed Facility Cross-Walk" Open Data table at: https://data.chhs.ca.gov/dataset/licensed-facility-crosswalk. For information about healthcare-associated infection prevention progress in California hospitals and statewide prevention goals, please visit: https://www.cdph.ca.gov/Programs/CHCQ/HAI/Pages/AnnualHAIReports.aspx

Dataset for a year long watershed study in southwestern Ohio to analyze antimicrobial resistant bacteria (E. coli, Enterococcus, and Salmonella) in surface waters and wastewater treatment plant effluent.